IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. // Molecular Therapy: Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S295032992600192X?dgcid=rss_sd_all
IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting. Molecular Therapy: Oncology. https://www.sciencedirect.com/science/article/pii/S295032992600192X?dgcid=rss_sd_all
“IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting.” Molecular Therapy: Oncology.
@article{article90276,
title = {IL-15 boosts mesothelin- and CD70-CAR NK cell potency in PDAC without added benefit from dual targeting},
journal = {Molecular Therapy: Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S295032992600192X?dgcid=rss_sd_all}
}